首页> 美国卫生研究院文献>Journal of Virology >Incorporation of Tumor Vasculature Targeting Motifs into Moloney Murine Leukemia Virus Env Escort Proteins Enhances Retrovirus Binding and Transduction of Human Endothelial Cells
【2h】

Incorporation of Tumor Vasculature Targeting Motifs into Moloney Murine Leukemia Virus Env Escort Proteins Enhances Retrovirus Binding and Transduction of Human Endothelial Cells

机译:靶向肿瘤脉管的母题纳入莫洛尼鼠白血病病毒env护送蛋白增强逆转录病毒结合和人类内皮细胞的转导。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adhesion receptors expressed on the surfaces of tumor-activated endothelial cells provide an advantageous locus for targeting gene therapy vectors to angiogenic tissues and/or tumor vasculature. In this study, we engineered a series of Asn-Gly-Arg (NGR)-containing congeners of the presumptive cell binding motif contained within the ninth type III repeat of fibronectin and displayed these tumor vasculature targeting motifs (TVTMs) within the context of Moloney murine leukemia envelope “escort” proteins. Comparative studies of envelope incorporation into viral particles and evaluation of the cell binding properties of the targeted vectors revealed critical structural features, thus identifying a subset of optimal TVTMs. Utilizing a modified ELISA to evaluate viral binding to target cells, we observed a significant down-regulation of TVTM-virion binding to human endothelial cells following sustained (48-h) exposure to VEGF. Normalized for equivalent titers (106 CFU/ml), as assayed on NIH 3T3 cells, vectors displaying TVTM escort proteins significantly enhanced the transduction efficiency from 12.2 to 37.4% in human KSY-1 endothelial cell cultures (P < 0.001) and from 0.4 to 4.1% in human umbilical vein endothelial cell (HUVEC) cultures (P < 0.001). In summary, these studies utilized an engineering approach to identify a subset of TVTMs that are stably incorporated as envelope “escort” proteins into retroviral vectors and that, by functioning to improve the binding efficiency and transduction of both HUVEC and KSY1 endothelial cells, may have therapeutic potential for targeting gene delivery to the tumor-associated vasculature.
机译:在肿瘤激活的内皮细胞表面表达的粘附受体为将基因治疗载体靶向血管生成组织和/或肿瘤脉管系统提供了有利的场所。在这项研究中,我们设计了一系列在纤连蛋白第九型III重复序列中包含的推定细胞结合基序的含Asn-Gly-Arg(NGR)同源物,并在Moloney的背景下展示了这些肿瘤脉管靶向基序(TVTM)。鼠白血病包膜“伴游”蛋白。包膜掺入病毒颗粒和评估靶向载体的细胞结合特性的比较研究揭示了关键的结构特征,从而确定了最佳TVTM的子集。利用改良的ELISA评估病毒与靶细胞的结合,我们观察到持续(48小时)暴露于VEGF后,TVTM-病毒体与人内皮细胞结合的显着下调。如在NIH 3T3细胞上测定的那样,对等效效价(10 6 CFU / ml)进行了标准化,显示TVTM伴游蛋白的载体在人KSY-1内皮细胞培养物中的转导效率从12.2显着提高到37.4%( P <0.001),在人脐静脉内皮细胞(HUVEC)培养中为0.4-4.1%(P <0.001)。总而言之,这些研究利用一种工程学方法来鉴定TVTM的一个子集,这些子集可以作为包膜“伴游”蛋白稳定地掺入逆转录病毒载体中,并且通过发挥功能来提高HUVEC和KSY1内皮细胞的结合效率和转导,可能具有靶向基因递送至肿瘤相关脉管系统的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号